← All Sponsors
SPONSOR

Huda Salman

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Chronic Myelomonocytic Leukemia
NCT06071624 Phase 1
Recruiting

Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.

Chronic Myelomonocytic Leukemia
United States View Trial →